James Investment Research’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-51
Closed -$2K 740
2019
Q1
$2K Sell
51
-26,219
-100% -$1.16M ﹤0.01% 804
2018
Q4
$1.08M Sell
26,270
-17,520
-40% -$752K 0.07% 295
2018
Q3
$2.05M Buy
43,790
+2,070
+5% +$94.6K 0.08% 378
2018
Q2
$1.82M Buy
41,720
+490
+1% +$22.8K 0.07% 417
2018
Q1
$1.89M Buy
+41,230
New +$2M 0.07% 346
2017
Q4
Sell
-34,400
Closed -$1.79M 817
2017
Q3
$1.79M Buy
+34,400
New +$1.68M 0.06% 323
2016
Q3
Sell
-36
Closed -$1K 570
2016
Q2
$1K Buy
+36
New +$1.4K ﹤0.01% 515
2013
Q4
Sell
-2,620
Closed -$110K 543
2013
Q3
$110K Hold
2,620
﹤0.01% 335
2013
Q2
$107K Buy
+2,620
New +$96.3K ﹤0.01% 330

Other funds holding MET

James Investment Research's MET Position: Q2 2019 in Review

James Investment Research sold out of MetLife (MET) in Q2 2019, closing a stake of 51 shares — an estimated $2K sold.

James Investment Research first reported a position in MET in Q2 2013 and held it in 9 quarters. The position peaked at $2.05M in Q3 2018. 1,038 funds tracked by Wall St. Rank hold MET as of Q2 2019.

  • James Investment Research reported no remaining MetLife position as of Q2 2019 after selling out during the quarter.
  • James Investment Research sold 51 MetLife shares in Q2 2019, an estimated $2K.
  • James Investment Research first reported a position in MetLife in Q2 2013 and held it in 9 quarters.
  • James Investment Research's MetLife position peaked at $2.05M in Q3 2018.
  • 1,038 funds tracked by Wall St. Rank held MetLife as of Q2 2019.

Based on James Investment Research's 13F filing for Q2 2019, filed 24 Jul 2019.